Lori Erickson
0000-0002-3666-2546
2 papers found
Refreshing results…
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma
Diameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: A case-control study
Missing publications? Search for publications with a matching author name.